Related Experiment Video
Updated: Apr 4, 2026
Mouse Round Spermatid Injection
Published on: January 26, 2024
Sperm Count Improvement in a Cancer-Surviving Patient
Maria Conceição Pereira1, Margarida M Vieira1, Joana Simões Pereira1
1Endocrinology Department, Portuguese Cancer Institute, Lisbon, Portugal.
Objective:
To describe the case of a cancer-surviving patient who was treated with an aromatase inhibitor for fertility reasons with successful results.
Clinical Case:
A 30-year-old patient from our institute who had been submitted to bone marrow transplantation in the past as part of treatment for Hodgkin's disease had revealed oligospermia several times. His sperm count mean value was 33,500 cells/ml. He was treated with an aromatase inhibitor (letrozole, 2 mg/day) for 8 months. After this period, his sperm count had increased significantly to 1,000,000 cells/ml.
Conclusion:
A large number of cancer survivors express a wish for having babies. After their cure, a lot of them have a low count of spermatozoids, and we think that our results show an easy way of helping them.
More Related Videos
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
01:21Cancer Survival Analysis
01:23Infertility in Males
02:56Treatment Resistant Cancers
01:41Spermatogenesis
02:56Treatment Resistent Cancers
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...